Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use

The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors.

Findings from this project will establish a framework for implementing prescriber-pharmacist collaboration for high risk medications, including anticoagulants

Please note that the 3rd and 4th outcome measures are conditional on the outcomes of the 1st and 2nd outcome measures respectively.

Please note that enrollment of 300 will provide sufficient power to study.

Study data was obtained through data downloads and not from individual participant interactions. Final data collection for all outcomes took place on Dec 15, 2024.

Prescribers:

Inclusion Criteria:

• Michigan Medicine provider with prescribing privileges
• Providers in ambulatory care settings
• Prescribe DOAC to patients 18 years and older

Exclusion Criteria:

• Providers in inpatient settings
• Providers who are members of the study team